News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
394,730 Results
Type
Article (26459)
Company Profile (60)
Press Release (368209)
Multimedia
Podcasts (34)
Webinars (7)
Section
Business (104673)
Career Advice (512)
Deals (16954)
Drug Delivery (53)
Drug Development (47794)
Employer Resources (47)
FDA (12360)
Job Trends (8503)
News (186814)
Policy (19544)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (1759)
Accelerated approval (14)
Adcomms (10)
Allergies (111)
Alliances (26966)
ALS (96)
Alzheimer's disease (974)
Antibody-drug conjugate (ADC) (161)
Approvals (12694)
Artificial intelligence (305)
Autoimmune disease (92)
Automation (8)
Bankruptcy (142)
Best Places to Work (6912)
BIOSECURE Act (5)
Biosimilars (73)
Biotechnology (40)
Bladder cancer (124)
Brain cancer (36)
Breast cancer (416)
Cancer (3067)
Cardiovascular disease (265)
Career advice (469)
Career pathing (15)
CAR-T (134)
CDC (26)
Celiac Disease (2)
Cell therapy (365)
Cervical cancer (26)
Clinical research (42985)
Collaboration (856)
Compensation (274)
Complete response letters (16)
COVID-19 (1557)
CRISPR (35)
C-suite (491)
Cystic fibrosis (59)
Data (4241)
Decentralized trials (2)
Denatured (20)
Depression (93)
Diabetes (318)
Diagnostics (3732)
Digital health (28)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (94)
Drug pricing (91)
Drug shortages (22)
Duchenne muscular dystrophy (124)
Earnings (38703)
Editorial (28)
Employer branding (6)
Employer resources (46)
Events (54352)
Executive appointments (586)
FDA (14645)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (12)
Funding (751)
Gene editing (75)
Generative AI (20)
Gene therapy (262)
GLP-1 (542)
Government (3146)
Grass and pollen (4)
Guidances (230)
Healthcare (12237)
HIV (38)
Huntington's disease (20)
IgA nephropathy (50)
Immunology and inflammation (81)
Immuno-oncology (26)
Indications (68)
Infectious disease (1689)
Inflammatory bowel disease (110)
Inflation Reduction Act (7)
Influenza (51)
Intellectual property (118)
Interviews (67)
IPO (7096)
IRA (23)
Job creations (1847)
Job search strategy (400)
JPM (18)
Kidney cancer (10)
Labor market (34)
Layoffs (195)
Leadership (8)
Legal (3654)
Liver cancer (66)
Longevity (7)
Lung cancer (483)
Lymphoma (250)
Machine learning (16)
Management (17)
Manufacturing (288)
MASH (105)
Medical device (13305)
Medtech (13350)
Mergers & acquisitions (10369)
Metabolic disorders (753)
Multiple sclerosis (100)
NASH (11)
Neurodegenerative disease (161)
Neuropsychiatric disorders (42)
Neuroscience (1696)
NextGen: Class of 2026 (3938)
Non-profit (2845)
Now hiring (33)
Obesity (311)
Opinion (97)
Ovarian cancer (119)
Pain (141)
Pancreatic cancer (141)
Parkinson's disease (164)
Partnered (17)
Patents (225)
Patient recruitment (352)
Peanut (42)
People (35712)
Pharmaceutical (15)
Pharmacy benefit managers (16)
Phase 1 (12359)
Phase 2 (18592)
Phase 3 (15275)
Pipeline (3064)
Policy (125)
Postmarket research (1670)
Preclinical (3813)
Press Release (18)
Prostate cancer (177)
Psychedelics (26)
Radiopharmaceuticals (179)
Rare diseases (429)
Real estate (2878)
Recruiting (18)
Regulatory (15706)
Reports (18)
Research institute (1658)
Resumes & cover letters (60)
Rett syndrome (16)
RNA editing (5)
RSV (39)
Schizophrenia (113)
Series A (116)
Series B (93)
Service/supplier (2)
Sickle cell disease (45)
Special edition (6)
Spinal muscular atrophy (104)
Sponsored (16)
Startups (2140)
Stomach cancer (11)
Supply chain (60)
Tariffs (25)
The Weekly (14)
Vaccines (507)
Venture capital (27)
Weight loss (210)
Women's health (54)
Worklife (4)
Date
Today (57)
Last 7 days (316)
Last 30 days (1095)
Last 365 days (16216)
2026 (1532)
2025 (16503)
2024 (19899)
2023 (22806)
2022 (30753)
2021 (33057)
2020 (32263)
2019 (28529)
2018 (21896)
2017 (18966)
2016 (18169)
2015 (21240)
2014 (16061)
2013 (13278)
2012 (14371)
2011 (14633)
2010 (13201)
Location
Africa (368)
Alabama (30)
Alaska (2)
Arizona (174)
Arkansas (10)
Asia (25509)
Australia (4039)
California (5596)
Canada (1915)
China (787)
Colorado (286)
Connecticut (285)
Delaware (249)
Europe (50213)
Florida (949)
Georgia (225)
Hawaii (1)
Idaho (35)
Illinois (578)
India (32)
Indiana (377)
Iowa (11)
Japan (317)
Kansas (90)
Kentucky (19)
Louisiana (18)
Maine (28)
Maryland (891)
Massachusetts (3744)
Michigan (149)
Minnesota (443)
Mississippi (5)
Missouri (79)
Montana (19)
Nebraska (21)
Nevada (65)
New Hampshire (73)
New Jersey (1927)
New Mexico (10)
New York (1568)
North Carolina (811)
North Dakota (4)
Northern California (2668)
Ohio (212)
Oklahoma (8)
Oregon (28)
Pennsylvania (1350)
Puerto Rico (11)
Rhode Island (35)
South America (523)
South Carolina (59)
Southern California (2238)
Tennessee (124)
Texas (1020)
United States (21655)
Utah (194)
Virginia (141)
Washington D.C. (52)
Washington State (386)
West Virginia (4)
Wisconsin (71)
Wyoming (1)
394,730 Results for "hansen medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary
May 21, 2025
·
4 min read
Press Releases
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary effective immediately
May 21, 2025
·
4 min read
Business
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care.
February 6, 2024
·
8 min read
Deals
The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner
On December 12, 2022, Novozymes and Chr. Hansen entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies.
January 29, 2024
·
8 min read
Deals
Novozymes and Chr. Hansen announce name of future combined company; Novonesis
Novozymes and Chr. Hansen announced their future name ‘Novonesis’. The name reflects the beginning of an era of biosolutions where Novonesis will unleash the full potential of biological solutions and generate significant value for all stakeholders and society at large.
December 13, 2023
·
13 min read
Business
LIfT BioSciences appoints Dr Bo Rode Hansen and Dr Marco Gottardis to its Board of Directors
LIfT BioSciences, a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy, announces the appointments of Dr Bo Rode Hansen PhD, MBA and Dr Marco Gottardis, PhD as Non-Executive Directors of its Board.
December 21, 2023
·
4 min read
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
·
2 min read
Press Releases
AVITA Medical Announces CEO Transition
October 17, 2025
·
5 min read
Bergen Prepares to Host International Conference on Hansen’s Disease Marking 150 Years Since the Discovery of the Leprosy Bacillus
The Sasakawa Leprosy (Hansen’s Disease) Initiative and the University of Bergen are organizing a two-day conference in Bergen, Norway, on June 21-22, 2023, to commemorate the 150 th anniversary of the discovery of M. leprae , the causative agent of leprosy, in 1873.
June 19, 2023
·
4 min read
Press Releases
Intricon becomes Forj Medical and Announces Opening Plans for its Advanced Manufacturing Facility in Costa Rica
Intricon completes construction of its Evolution Free Zone location, combines with Minnetronix Medical, and will fly the Forj Medical flag at its new site; equipment and workforce move into place for the grand opening
December 9, 2025
·
1 min read
1 of 39,473
Next
